CannaPharmaRx, Inc. (CPMD)
CannaPharmaRx Market Cap: 3.644M for Jan. 15, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Oncolytics Biotech, Inc. | 104.70M |
| Aurinia Pharmaceuticals, Inc. | 1.960B |
| Edesa Biotech, Inc. | 9.982M |
| Lexaria Bioscience Corp. | 18.19M |
| Xenon Pharmaceuticals, Inc. | 3.148B |
Market Cap Related Metrics
| PS Ratio | 2.126 |
| PEG Ratio | -0.0108 |
| Price | 0.0055 |
| Earnings Yield | -201.8% |
| PEGY Ratio | -0.0108 |